IMAGE: Lehigh University engineers, Xuanhong Cheng associate professor of materials science and engineering, and James Hwang, professor of electrical engineering and computer science, awarded National Science Foundation grant to explore the… view more
Credit: Lehigh University
To test for malignancy or monitor the effectiveness of cancer treatment, a person’s tissue must be extracted, sent to a lab, stained and analyzed by a pathologist–a process that can take days to complete and is subject to human error.
These two Lehigh University engineers are envisioning a future where cancer screening and treatment monitoring will be conducted at the point of care using microwave technology to characterize the nucleus of a single cell captured on a small microfluidic device. This lab-on-a-chip method would not only have the advantage of being portable, but would also be faster, cheaper, and more streamlined than currently available methods. The duo were recently awarded a three-year grant by National Science Foundation (NSF) to explore this unique approach.
Cheng and Hwang’s technology begins with a microfluidic device that can capture–and then release–a single cell.
Article originally posted at